E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/11/2024 in the Prospect News Structured Products Daily.

New Issue: Morgan Stanley prices $528,000 11.25% fixed-income buffered securities on stocks

Chicago, Feb. 11 – Morgan Stanley Finance LLC priced $528,000 of fixed-income buffered securities due May 29, 2025 linked to the worst performing of the common stocks of Bank of America Corp., Target Corp. and UnitedHealth Group Inc., according to a 424B2 filing with the Securities and Exchange Commission.

Investors will receive a coupon of 11.25%, paid monthly.

If the worst performing stock gains or declines by no more than the 20% buffer the payout at maturity will be par. Investors will lose 1% for every 1% that the worst performing stock declines beyond the buffer.

The notes are non-callable.

The notes are guaranteed by Morgan Stanley.

Morgan Stanley & Co. LLC is the agent.

Issuer:Morgan Stanley Finance LLC
Guarantor:Morgan Stanley
Issue:Fixed-income buffered securities
Underlying stocks:Bank of America Corp., Target Corp. and UnitedHealth Group Inc.
Amount:$528,000
Maturity:May 29, 2025
Coupon:11.25% annual rate, paid monthly
Price:Par
Payout at maturity:If worst performing stock finishes at or above its buffer, par; 1% loss for every 1% that worst performing stock declines beyond its buffer level
Initial levels:$28.58 for BofA, $147.16 for Target, $479.44 for UnitedHealth
Buffer levels:$22.864 for BofA, $117.728 for Target, $383.552 for UnitedHealth; 80% of initial levels
Buffer:20%
Call:Non-callable
Pricing date:May 24, 2023
Settlement date:May 30, 2023
Agent:Morgan Stanley & Co. LLC
Fees:0.4%
Cusip:61774XY98

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.